These findings correspond to an adenosine-producing human melanoma cell line, showing higher suppression of CD8 T cell proliferation than CD4 T cells.54 A2BAR antagonists were subsequently shown to inhibit extracellular ADO uptake via downstream pAMPK in total CD4 and CD8 T cells. Here, ADO is linked to melanoma.